PROLONGATION OF FETAL PANCREAS ALLOGRAFT SURVIVAL IN MICE TREATED WITH ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY (PC61) CONJUGATED WITH IDARUBICIN

被引:0
|
作者
KOULMANDA, M
PIETERSZ, G
MCKENZIE, IFC
MANDEL, TE
机构
[1] UNIV MELBOURNE,ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,TRANSPLANTAT UNIT,MELBOURNE,VIC 3050,AUSTRALIA
[2] UNIV MELBOURNE,DEPT PATHOL,PARKVILLE,VIC 3052,AUSTRALIA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2113 / 2114
页数:2
相关论文
共 46 条
  • [31] PROPHYLACTIC USE OF THE ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1 IN CADAVERIC RENAL-TRANSPLANTATION - RESULTS OF A RANDOMIZED STUDY
    KRIAA, F
    HIESSE, C
    ALARD, P
    LANTZ, O
    NOURY, J
    CHARPENTIER, B
    BAZIN, H
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 817 - 819
  • [32] Decrease in the degree of lymphosplenomegaly and in the serum IFN-γ concentration but not in the production of IgG and anti-DNA antibody in BXSB mice treated with Anti-IL-2 receptor β antibody
    Takeshima, M
    Habu, Y
    Hiraide, H
    Seki, S
    BIOMEDICAL RESEARCH-TOKYO, 2002, 23 (01): : 29 - 35
  • [33] PROLONGATION OF RAT PANCREATIC-ISLET ALLOGRAFT SURVIVAL BY TREATMENT OF RECIPIENT RATS WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY AND CYCLOSPORINE
    HAHN, HJ
    KUTTLER, B
    DUNGER, A
    KLOTING, I
    LUCKE, S
    VOLK, HD
    VONBAEHR, R
    DIAMANTSTEIN, T
    DIABETOLOGIA, 1987, 30 (01) : 44 - 46
  • [34] PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN IDENTICAL SIBLING DONOR BMT BY ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1
    FERRANT, A
    LATINNE, D
    BAZIN, H
    STRAETMANS, N
    CORNET, A
    DELAPARRA, B
    MICHAUX, JL
    BLOOD, 1994, 84 (10) : A158 - A158
  • [35] EFFECT OF ANTI-CD4 AND ANTI-CD8 MONOCLONAL-ANTIBODY TREATMENT ON FETAL PIG PANCREAS XENOGRAFT SURVIVAL IN NONOBESE DIABETIC LT FEMALE MICE
    MANDEL, TE
    KOULMANDA, M
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) : 216 - 217
  • [36] PROLONGATION OF ALLOGENEIC ISLET GRAFTS IN SPONTANEOUSLY DIABETIC BB/OK RATS AFTER SHORT-TERM RECIPIENT TREATMENT WITH MONOCLONAL ANTI-IL-2 RECEPTOR ANTIBODY AND CYCLOSPORINE
    HAHN, HJ
    KUTTLER, B
    VOLK, HD
    DUNGER, A
    LUCKE, S
    BESCH, W
    VONBAEHR, R
    DIAMANTSTEIN, T
    DIABETES, 1989, 38 : 286 - 287
  • [37] POTENT AND EFFECTIVE PROLONGATION BY ANTI-LFA-1 MONOCLONAL-ANTIBODY MONOTHERAPY OF NON-PRIMARILY VASCULARIZED HEART ALLOGRAFT SURVIVAL IN MICE WITHOUT T-CELL DEPLETION
    NAKAKURA, EK
    MCCABE, SM
    ZHENG, B
    SHORTHOUSE, RA
    SCHEINER, TM
    BLANK, G
    JARDIEU, PM
    MORRIS, RE
    TRANSPLANTATION, 1993, 55 (02) : 412 - 417
  • [38] PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN IDENTICAL SIBLING DONOR BONE-MARROW TRANSPLANT BY ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1
    FERRANT, A
    LATINNE, D
    BAZIN, H
    STRAETMANS, N
    CORNET, A
    DELAPARRA, B
    MICHAUX, JL
    BONE MARROW TRANSPLANTATION, 1995, 16 (04) : 577 - 581
  • [39] MONOCLONAL-ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION - A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI-IL-2 RECEPTOR MONOCLONAL-ANTIBODY LO-TACT-1
    REDING, R
    VRAUX, H
    DEGOYET, JD
    SOKAL, E
    DEHEMPTINNE, B
    LATINNE, D
    RAHIER, J
    JAMART, J
    VINCENZOTTO, C
    CORMONT, F
    DELAPARRA, B
    DEBRUYERE, M
    SOKAL, G
    BAZIN, H
    OTTE, JB
    TRANSPLANTATION, 1993, 55 (03) : 534 - 541
  • [40] ANTI-CD3 - ANTI-IL2 RECEPTOR (CD3,25) BISPECIFIC MONOCLONAL-ANTIBODY (BSMAB) - PREVENTION OF DIABETES IN NONOBESE DIABETIC (NOD) MICE
    WONG, JT
    MACLEAN, JA
    COLVIN, RB
    FASEB JOURNAL, 1994, 8 (05): : A967 - A967